• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2020 年科特迪瓦洛美(多哥)高危人群中 SARS-CoV-2 的流行情况。

Prevalence of SARS-CoV-2 among high-risk populations in Lomé (Togo) in 2020.

机构信息

Institut National d'Hygiène (INH), Lomé, Togo.

Département de Santé Publique, Université de Lomé, Lomé, Togo.

出版信息

PLoS One. 2020 Nov 9;15(11):e0242124. doi: 10.1371/journal.pone.0242124. eCollection 2020.

DOI:10.1371/journal.pone.0242124
PMID:33166369
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7652308/
Abstract

BACKGROUND

In December 2019, the COVID-19 outbreak began in China and quickly spread throughout the world and was reclassified as a pandemic in March 2020. The first case of COVID-19 was declared in Togo on March 5. Two months later, few data were available to describe the circulation of the new coronavirus in the country.

OBJECTIVE

This survey aimed to estimate the prevalence of SARS-CoV-2 in high-risk populations in Lomé.

MATERIALS AND METHODS

From April 23, 2020, to May 8, 2020, we recruited a sample of participants from five sectors: health care, air transport, police, road transport and informal. We collected oropharyngeal swabs for direct detection through real-time reverse transcription polymerase chain reaction (rRT-PCR) and blood for antibody detection by serological tests. The overall prevalence (current and past) of infection was defined by positivity for both tests.

RESULTS

A total of 955 participants with a median age of 36 (IQR 32-43) were included, and 71.6% (n = 684) were men. Approximately 22.1% (n = 212) were from the air transport sector, 20.5% (n = 196) were from the police sector, and 38.7% (n = 370) were from the health sector. Seven participants (0.7%, 95% CI: 0.3-1.6%) had a positive rRT-PCR test result at the time of recruitment, and nine (0.9%, 95% CI: 0.4-1.8%) were seropositive for IgM or IgG against SARS-CoV-2. We found an overall prevalence of 1.6% (n = 15), 95% CI: 0.9-2.6%.

CONCLUSION

The prevalence of SARS-CoV-2 infection among high-risk populations in Lomé was relatively low and could be explained by the various measures taken by the Togolese government. Therefore, we recommend targeted screening.

摘要

背景

2019 年 12 月,COVID-19 疫情在中国爆发,并迅速蔓延至全球,并于 2020 年 3 月被重新归类为大流行。第一例 COVID-19 病例于 3 月 5 日在多哥宣布。两个月后,几乎没有数据可用于描述该国新冠状病毒的传播情况。

目的

本调查旨在估计洛美高危人群中 SARS-CoV-2 的流行率。

材料和方法

从 2020 年 4 月 23 日至 5 月 8 日,我们从五个部门(医疗保健、航空运输、警察、道路运输和非正规部门)招募了一个样本。我们采集了口咽拭子进行实时逆转录聚合酶链反应(rRT-PCR)直接检测,并采集血液进行血清学检测以检测抗体。通过两种检测均为阳性来定义当前和过去的总体感染率(感染率)。

结果

共纳入 955 名中位年龄为 36 岁(IQR 32-43)的参与者,其中 71.6%(n=684)为男性。大约 22.1%(n=212)来自航空运输部门,20.5%(n=196)来自警察部门,38.7%(n=370)来自医疗保健部门。7 名参与者(0.7%,95%CI:0.3-1.6%)在招募时 rRT-PCR 检测结果为阳性,9 名参与者(0.9%,95%CI:0.4-1.8%)针对 SARS-CoV-2 的 IgM 或 IgG 呈血清阳性。我们发现总体感染率为 1.6%(n=15),95%CI:0.9-2.6%。

结论

洛美高危人群中 SARS-CoV-2 感染的流行率相对较低,这可能是由于多哥政府采取的各种措施。因此,我们建议进行有针对性的筛查。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f70/7652308/eea635dea586/pone.0242124.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f70/7652308/eea635dea586/pone.0242124.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f70/7652308/eea635dea586/pone.0242124.g001.jpg

相似文献

1
Prevalence of SARS-CoV-2 among high-risk populations in Lomé (Togo) in 2020.2020 年科特迪瓦洛美(多哥)高危人群中 SARS-CoV-2 的流行情况。
PLoS One. 2020 Nov 9;15(11):e0242124. doi: 10.1371/journal.pone.0242124. eCollection 2020.
2
COVID-19 and lombardy: TESTing the impact of the first wave of the pandemic.COVID-19 和伦巴第大区:测试大流行第一波的影响。
EBioMedicine. 2020 Nov;61:103069. doi: 10.1016/j.ebiom.2020.103069. Epub 2020 Oct 22.
3
Antibody responses to SARS-CoV-2 in patients with differing severities of coronavirus disease 2019.新冠肺炎患者不同严重程度的新冠病毒抗体反应。
PLoS One. 2020 Oct 9;15(10):e0240502. doi: 10.1371/journal.pone.0240502. eCollection 2020.
4
Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study.SARS-CoV-2 感染后口咽后唾液样本和血清抗体反应中的病毒载量时间特征:一项观察性队列研究。
Lancet Infect Dis. 2020 May;20(5):565-574. doi: 10.1016/S1473-3099(20)30196-1. Epub 2020 Mar 23.
5
Detection and quantification of SARS-CoV-2 by droplet digital PCR in real-time PCR negative nasopharyngeal swabs from suspected COVID-19 patients.实时荧光定量 PCR 阴性的疑似 COVID-19 患者鼻咽拭子中通过液滴数字 PCR 检测和定量 SARS-CoV-2。
PLoS One. 2020 Sep 8;15(9):e0236311. doi: 10.1371/journal.pone.0236311. eCollection 2020.
6
Epidemiology of SARS-CoV-2 antibodies among firefighters/paramedics of a US fire department: a cross-sectional study.美国消防部门消防员/护理人员中 SARS-CoV-2 抗体的流行病学:一项横断面研究。
Occup Environ Med. 2020 Dec;77(12):857-861. doi: 10.1136/oemed-2020-106676. Epub 2020 Aug 6.
7
Seroprevalence of antibodies against SARS-CoV-2 among health care workers in a large Spanish reference hospital.西班牙一家大型教学医院医护人员中 SARS-CoV-2 抗体的血清阳性率。
Nat Commun. 2020 Jul 8;11(1):3500. doi: 10.1038/s41467-020-17318-x.
8
Assessment of self-medication practices in the context of the COVID-19 outbreak in Togo.多哥 COVID-19 疫情背景下的自我用药情况评估。
BMC Public Health. 2021 Jan 6;21(1):58. doi: 10.1186/s12889-020-10145-1.
9
Clinical and virologic characteristics of the first 12 patients with coronavirus disease 2019 (COVID-19) in the United States.美国首批 12 例 2019 年冠状病毒病(COVID-19)患者的临床和病毒学特征。
Nat Med. 2020 Jun;26(6):861-868. doi: 10.1038/s41591-020-0877-5. Epub 2020 Apr 23.
10
Prevalence of Sars-Cov-2 Infection in Health Workers (HWs) and Diagnostic Test Performance: The Experience of a Teaching Hospital in Central Italy.意大利中部一所教学医院的卫生工作者(HWs)中 SARS-CoV-2 感染的流行率和诊断检测性能。
Int J Environ Res Public Health. 2020 Jun 19;17(12):4417. doi: 10.3390/ijerph17124417.

引用本文的文献

1
A comparative cross-sectional study of the impact of COVID-19 pandemic on obstetrics and gynecology admissions in Croatia.一项关于新冠疫情对克罗地亚妇产科住院情况影响的比较横断面研究。
Front Med (Lausanne). 2025 Feb 14;12:1505387. doi: 10.3389/fmed.2025.1505387. eCollection 2025.
2
Seroprevalence and risk factors for SARS-CoV-2 infection in middle-sized cities of Burkina Faso: A descriptive cross-sectional study.布基纳法索中等城市 SARS-CoV-2 感染的血清流行率和危险因素:一项描述性横断面研究。
PLoS One. 2024 Aug 7;19(8):e0305850. doi: 10.1371/journal.pone.0305850. eCollection 2024.
3
Pre-vaccination seroprevalence of SARS-CoV-2 antibodies in the Volta Region, Ghana.

本文引用的文献

1
COVID-19 antibody seroprevalence in Santa Clara County, California.加利福尼亚州圣克拉拉县的新冠病毒抗体血清流行率。
Int J Epidemiol. 2021 May 17;50(2):410-419. doi: 10.1093/ije/dyab010.
2
First 100 Persons with COVID-19 - Zambia, March 18-April 28, 2020.2020 年 3 月 18 日至 4 月 28 日,赞比亚首批 100 例新冠肺炎病例。
MMWR Morb Mortal Wkly Rep. 2020 Oct 23;69(42):1547-1548. doi: 10.15585/mmwr.mm6942a5.
3
Nasopharyngeal Swabs Are More Sensitive Than Oropharyngeal Swabs for COVID-19 Diagnosis and Monitoring the SARS-CoV-2 Load.
加纳沃尔特地区新冠病毒抗体的疫苗接种前血清阳性率。
IJID Reg. 2024 Jan 20;10:179-182. doi: 10.1016/j.ijregi.2024.01.007. eCollection 2024 Mar.
4
Sero-prevalence of anti-SARS-CoV-2 antibodies among communities between July and August 2022 in Bangui, Central African Republic.2022年7月至8月期间,中非共和国班吉各社区抗新冠病毒2抗体的血清流行率。
J Public Health Afr. 2023 Jun 5;14(8):2315. doi: 10.4081/jphia.2023.2315. eCollection 2023 Aug 7.
5
Epidemiological, clinical, therapeutic features and predictors of death among COVID-19 patients hospitalized in Parakou: a cross-sectional study in Northern Benin.贝宁北部帕拉库医院收治的 COVID-19 患者的流行病学、临床、治疗特征和死亡预测因素:横断面研究。
BMC Infect Dis. 2023 Jul 20;23(1):484. doi: 10.1186/s12879-023-08445-z.
6
Plasmodium infection is associated with cross-reactive antibodies to carbohydrate epitopes on the SARS-CoV-2 Spike protein.疟原虫感染与针对 SARS-CoV-2 刺突蛋白上碳水化合物表位的交叉反应性抗体有关。
Sci Rep. 2022 Dec 22;12(1):22175. doi: 10.1038/s41598-022-26709-7.
7
SARS CoV-2 Seroprevalence in Selected States of High and Low Disease Burden in Nigeria.尼日利亚高、低疾病负担州份的 SARS-CoV-2 血清流行率。
JAMA Netw Open. 2022 Oct 3;5(10):e2236053. doi: 10.1001/jamanetworkopen.2022.36053.
8
SARS-CoV-2 Seroprevalence in Those Utilizing Public Transportation or Working in the Transportation Industry: A Rapid Review.利用公共交通工具或从事交通运输业人员的 SARS-CoV-2 血清流行率:快速综述。
Int J Environ Res Public Health. 2022 Sep 15;19(18):11629. doi: 10.3390/ijerph191811629.
9
Prevalence of Malaria and Covid-19 in Febrile Patients in Lomé, Togo in 2020.2020 年多哥洛美发热患者疟疾和新冠病毒感染的流行情况。
Acta Parasitol. 2022 Sep;67(3):1335-1342. doi: 10.1007/s11686-022-00586-6. Epub 2022 Jul 14.
10
Serosurveillance after a COVID-19 vaccine campaign in a Swiss police cohort.瑞士警察队列中 COVID-19 疫苗接种后的血清监测。
Immun Inflamm Dis. 2022 Jul;10(7):e640. doi: 10.1002/iid3.640.
对于2019冠状病毒病(COVID-19)的诊断和监测严重急性呼吸综合征冠状病毒2(SARS-CoV-2)载量,鼻咽拭子比口咽拭子更敏感。
Front Med (Lausanne). 2020 Jun 18;7:334. doi: 10.3389/fmed.2020.00334. eCollection 2020.
4
Estimating the burden of SARS-CoV-2 in France.估算法国 SARS-CoV-2 的负担。
Science. 2020 Jul 10;369(6500):208-211. doi: 10.1126/science.abc3517. Epub 2020 May 13.
5
Screening of healthcare workers for SARS-CoV-2 highlights the role of asymptomatic carriage in COVID-19 transmission.对医护人员进行 SARS-CoV-2 筛查突出了无症状携带在 COVID-19 传播中的作用。
Elife. 2020 May 11;9:e58728. doi: 10.7554/eLife.58728.
6
Interpreting Diagnostic Tests for SARS-CoV-2.解读新型冠状病毒2019(SARS-CoV-2)诊断检测结果
JAMA. 2020 Jun 9;323(22):2249-2251. doi: 10.1001/jama.2020.8259.
7
[The diagnostic value of rapid anti IgM and IgG detecting tests in the identification of patients with SARS CoV-2 virus infection].[快速抗IgM和IgG检测试验在新型冠状病毒肺炎病毒感染患者识别中的诊断价值]
Orv Hetil. 2020 May 1;161(20):807-812. doi: 10.1556/650.2020.31859.
8
Assessment of SARS-CoV-2 Infection Prevalence in Homeless Shelters - Four U.S. Cities, March 27-April 15, 2020.评估无家可归者收容所中的 SARS-CoV-2 感染率-2020 年 3 月 27 日至 4 月 15 日,美国四个城市。
MMWR Morb Mortal Wkly Rep. 2020 May 1;69(17):521-522. doi: 10.15585/mmwr.mm6917e1.
9
Characteristics of patients with coronavirus disease (COVID-19) confirmed using an IgM-IgG antibody test.采用 IgM-IgG 抗体检测方法确诊的新型冠状病毒肺炎(COVID-19)患者的特征。
J Med Virol. 2020 Oct;92(10):2004-2010. doi: 10.1002/jmv.25930. Epub 2020 May 7.
10
Comparison of nasopharyngeal and oropharyngeal swabs for SARS-CoV-2 detection in 353 patients received tests with both specimens simultaneously.比较 353 例同时接受两种标本检测的患者的鼻咽拭子和口咽拭子在 SARS-CoV-2 检测中的应用。
Int J Infect Dis. 2020 May;94:107-109. doi: 10.1016/j.ijid.2020.04.023. Epub 2020 Apr 18.